Literature DB >> 22578881

First report of elective selective neck dissection in the management of squamous cell carcinoma of the maxillary sinus.

James S Brown1, Fazilet Bekiroglu, Richard J Shaw, Julia A Woolgar, Asterios Triantafyllou, Simon N Rogers.   

Abstract

Controversy remains about management of the neck in squamous cell carcinoma (SCC) of the maxillary sinus and we know of no reports of the use of elective selective neck dissection for management in this site. We retrospectively reviewed 18 consecutive patients with SCC of the maxillary sinus who were managed by primary operation with curative intent. A total of 13 patients had an elective selective neck dissection, which was invaded in one case 8%. Four patients had regional metastases, two with positive nodal disease confirmed after elective selective neck dissection, and two who developed regional recurrence (both after elective selective neck dissections which were negative (pN0)). A review of other published articles in the English language showed no cases of elective selective neck dissections reported. The mean regional recurrence rate was 12% (range 0-26%) and total mean regional metastases rate 21% (range 5-36%). Elective selective neck dissection did not contribute to an improved rate of neck control with regional recurrence of 11% (2/18) compared with 12% in the review. There is no evidence in this report to indicate that elective selective neck dissections for maxillary sinus SCC will result in better disease control. Future research may indicate fewer radiotherapy fields for necks with pathologically clear nodes after elective selective neck dissection.
Copyright © 2012 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22578881     DOI: 10.1016/j.bjoms.2012.04.004

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  9 in total

1.  Sinonasal squamous cell carcinoma without clinical lymph node involvement : Which neck management is best?

Authors:  Pauline Castelnau-Marchand; Antonin Levy; Antoine Moya-Plana; Haïtham Mirghani; France Nguyen; Eleonor Rivin Del Campo; François Janot; Frédéric Kolb; François-Régis Ferrand; Stéphane Temam; Pierre Blanchard; Yungan Tao
Journal:  Strahlenther Onkol       Date:  2016-06-20       Impact factor: 3.621

Review 2.  Management of the neck in maxillary sinus carcinomas.

Authors:  Laura Dooley; Jatin Shah
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2015-04       Impact factor: 2.064

Review 3.  Squamous cell carcinoma at maxillary sinus: clinicopathologic data in a single Brazilian institution with review of literature.

Authors:  Marcello Roter M Santos; João Paulo S Servato; Sérgio Vitorino Cardoso; Paulo Rogério de Faria; Ana Lúcia A Eisenberg; Fernando Luiz Dias; Adriano Mota Loyola
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

4.  The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.

Authors:  Tomohiro Sakashita; Akihiro Homma; Hiromitsu Hatakeyama; Satoshi Kano; Takatsugu Mizumachi; Jun Furusawa; Daisuke Yoshida; Noriyuki Fujima; Rikiya Onimaru; Kazuhiko Tsuchiya; Koichi Yasuda; Hiroki Shirato; Satoshi Fukuda
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-09       Impact factor: 2.503

Review 5.  The controversy in the management of the N0 neck for squamous cell carcinoma of the maxillary sinus.

Authors:  Robert P Takes; Alfio Ferlito; Carl E Silver; Alessandra Rinaldo; Jesus E Medina; K Thomas Robbins; Juan P Rodrigo; Marc Hamoir; Carlos Suárez; Peter Zbären; Vanni Mondin; Ashok R Shaha; William M Mendenhall; Primož Strojan
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-20       Impact factor: 2.503

6.  Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy.

Authors:  Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Hiroshi Idogawa; Daisuke Yoshida; Koichi Yasuda; Manami Otsuka; Hidefumi Aoyama; Akihiro Homma
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-18       Impact factor: 2.503

7.  Is elective neck dissection needed in squamous cell carcinoma of maxilla?

Authors:  Jung-Hyun Park; Woong Nam; Hyung Jun Kim; In-Ho Cha
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-06-28

8.  Importance of elective neck dissection in cN0 maxillary squamous cell carcinoma.

Authors:  Ik Jae Kwon; Soung Min Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2018-02-26

9.  Changing trends in the microvascular reconstruction and oral rehabilitation following maxillary cancer.

Authors:  Simon N Rogers; Ashni Adatia; Stephanie Hackett; Angela Boscarino; Anika Patel; Derek Lowe; Christopher J Butterworth
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-02-01       Impact factor: 3.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.